دورية أكاديمية

Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study.

التفاصيل البيبلوغرافية
العنوان: Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study.
المؤلفون: Trifi, Ahlem, Abdellatif, Sami, Abdennebi, Cyrine, Daly, Foued, Nasri, Rochdi, Touil, Yosr, Ben Lakhal, Salah
المصدر: Annals of Clinical Microbiology & Antimicrobials; 11/16/2018, Vol. 17 Issue 1, p1-11, 11p
مصطلحات موضوعية: SEPTICEMIA treatment, ANTI-infective agents, IMIPENEM, COLISTIN, COHORT analysis
مستخلص: Background: Empiric antimicrobial therapy (EAMT) using imipenem/colistin is commonly prescribed as a first line therapy in critically ill patients with severe sepsis. We aimed to assess the appropriateness of prescribing imipenem/colistin as EAMT in ICU patients. Methods: A 3-year observational prospective study included ICU patients that required imipenem/colistin as EAMT. The EAMT was assessed according to microbiological and clinical outcomes. The outcomes were: delay in apyrexia, delay in the decrease of the biological inflammatory parameters (BIP), the requirement for vasoactive agents, bacteriological eradication, length of stay, ventilator days and 30-day mortality. Results: 79 administrations of EAMT in 70 patients were studied. EAMT was appropriate in 52% of the studied cases. An ICU stay > 6 days was related to inappropriateness, and chronic respiratory failure was associated with appropriateness. In the appropriate EAMT group, we showed: earlier apyrexia, shorter delay in the decrease of the BIP and a reduced significant vasopressors requirement. Furthermore, EAMT improved survival with a median gain of 4 days. Inappropriate EAMT increased the mortality risk by six. The acquisition of NI in ICU was also an independent factor of mortality. Conclusions: EAMT using imipenem-colistin was appropriate in half of the cases and inappropriateness was associated with an increased ICU mortality risk. [ABSTRACT FROM AUTHOR]
Copyright of Annals of Clinical Microbiology & Antimicrobials is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14760711
DOI:10.1186/s12941-018-0292-7